SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-016735
Filing Date
2022-11-08
Accepted
2022-11-08 07:15:19
Documents
21
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20221108x8k.htm   iXBRL 8-K 49032
2 EX-99.1 acrs-20221108xex99d1.htm EX-99.1 196129
3 EX-99.2 acrs-20221108xex99d2.htm EX-99.2 11698
4 GRAPHIC acrs-20221108xex99d2g006.jpg GRAPHIC 155359
5 GRAPHIC acrs-20221108xex99d2g002.jpg GRAPHIC 193759
6 GRAPHIC acrs-20221108xex99d2g004.jpg GRAPHIC 134637
7 GRAPHIC acrs-20221108xex99d2g003.jpg GRAPHIC 203476
8 GRAPHIC acrs-20221108xex99d2g005.jpg GRAPHIC 147981
9 GRAPHIC acrs-20221108xex99d2g001.jpg GRAPHIC 196551
10 GRAPHIC acrs-20221108xex99d1001.jpg GRAPHIC 13042
  Complete submission text file 0001558370-22-016735.txt   1836384

Data Files

Seq Description Document Type Size
11 EX-101.SCH acrs-20221108.xsd EX-101.SCH 3054
12 EX-101.LAB acrs-20221108_lab.xml EX-101.LAB 16012
13 EX-101.PRE acrs-20221108_pre.xml EX-101.PRE 10319
15 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20221108x8k_htm.xml XML 4842
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 221367201
SIC: 2834 Pharmaceutical Preparations